These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 11923635)
1. Rasmussen's encephalitis: a role for autoimmune cytotoxic T lymphocytes. Bauer J; Bien CG; Lassmann H Curr Opin Neurol; 2002 Apr; 15(2):197-200. PubMed ID: 11923635 [TBL] [Abstract][Full Text] [Related]
2. Advances in pathogenic concepts and therapeutic agents in Rasmussen's encephalitis. Bien CG; Elger CE; Wiendl H Expert Opin Investig Drugs; 2002 Jul; 11(7):981-9. PubMed ID: 12084008 [TBL] [Abstract][Full Text] [Related]
4. Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen's encephalitis. Bien CG; Bauer J; Deckwerth TL; Wiendl H; Deckert M; Wiestler OD; Schramm J; Elger CE; Lassmann H Ann Neurol; 2002 Mar; 51(3):311-8. PubMed ID: 11891826 [TBL] [Abstract][Full Text] [Related]
5. GluR3 autoantibodies destroy neural cells in a complement-dependent manner modulated by complement regulatory proteins. Whitney KD; McNamara JO J Neurosci; 2000 Oct; 20(19):7307-16. PubMed ID: 11007888 [TBL] [Abstract][Full Text] [Related]
6. Autoimmunity to the glutamate receptor in mice--a model for Rasmussen's encephalitis? Levite M; Hermelin A J Autoimmun; 1999 Aug; 13(1):73-82. PubMed ID: 10441170 [TBL] [Abstract][Full Text] [Related]
7. Antibodies to AMPA receptors in Rasmussen's encephalitis. Nibber A; Clover L; Pettingill P; Waters P; Elger CE; Bien CG; Vincent A; Lang B Eur J Paediatr Neurol; 2016 Mar; 20(2):222-227. PubMed ID: 26785913 [TBL] [Abstract][Full Text] [Related]
8. Autoantibodies and cell-mediated autoimmunity to NMDA-type GluRepsilon2 in patients with Rasmussen's encephalitis and chronic progressive epilepsia partialis continua. Takahashi Y; Mori H; Mishina M; Watanabe M; Kondo N; Shimomura J; Kubota Y; Matsuda K; Fukushima K; Shiroma N; Akasaka N; Nishida H; Imamura A; Watanabe H; Sugiyama N; Ikezawa M; Fujiwara T Epilepsia; 2005; 46 Suppl 5():152-8. PubMed ID: 15987271 [TBL] [Abstract][Full Text] [Related]
9. Antibodies against GluR3 peptides are not specific for Rasmussen's encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures. Mantegazza R; Bernasconi P; Baggi F; Spreafico R; Ragona F; Antozzi C; Bernardi G; Granata T J Neuroimmunol; 2002 Oct; 131(1-2):179-85. PubMed ID: 12458050 [TBL] [Abstract][Full Text] [Related]
10. GluR3 antibodies: prevalence in focal epilepsy but no specificity for Rasmussen's encephalitis. Wiendl H; Bien CG; Bernasconi P; Fleckenstein B; Elger CE; Dichgans J; Mantegazza R; Melms A Neurology; 2001 Oct; 57(8):1511-4. PubMed ID: 11673604 [TBL] [Abstract][Full Text] [Related]
18. [THE ROLE OF AUTOANTIBODIES TO THE EXTRACELLULAR REGIONS OF IONOTROPIC RECEPTORS IN ETIOLOGY AND PATHOGENESIS OF AUTOIMMUNE DISEASES]. Zharova OA; Shpakov AO Ross Fiziol Zh Im I M Sechenova; 2016 Jul; 102(7):773-91. PubMed ID: 30193046 [TBL] [Abstract][Full Text] [Related]
19. Rasmussen's encephalitis with concomitant cortical dysplasia: the role of GluR3. Palmer CA; Geyer JD; Keating JM; Gilliam F; Kuzniecky RI; Morawetz RB; Bebin EM Epilepsia; 1999 Feb; 40(2):242-7. PubMed ID: 9952274 [TBL] [Abstract][Full Text] [Related]
20. Neurons under T Cell Attack Coordinate Phagocyte-Mediated Synaptic Stripping. Di Liberto G; Pantelyushin S; Kreutzfeldt M; Page N; Musardo S; Coras R; Steinbach K; Vincenti I; Klimek B; Lingner T; Salinas G; Lin-Marq N; Staszewski O; Costa Jordão MJ; Wagner I; Egervari K; Mack M; Bellone C; Blümcke I; Prinz M; Pinschewer DD; Merkler D Cell; 2018 Oct; 175(2):458-471.e19. PubMed ID: 30173917 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]